0001387131-18-001513.txt : 20180410
0001387131-18-001513.hdr.sgml : 20180410
20180410175116
ACCESSION NUMBER: 0001387131-18-001513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180406
FILED AS OF DATE: 20180410
DATE AS OF CHANGE: 20180410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cannon Louis A
CENTRAL INDEX KEY: 0001700257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37406
FILM NUMBER: 18748814
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD, SUITE 105
CITY: WALTHAM
STATE: ME
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc.
CENTRAL INDEX KEY: 0001528557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 300687898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 508-653-3335
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: Your Internet Defender, Inc
DATE OF NAME CHANGE: 20110824
4
1
cannon-form4_040618.xml
OWNERSHIP DOCUMENT
X0306
4
2018-04-06
0
0001528557
Corindus Vascular Robotics, Inc.
CVRS
0001700257
Cannon Louis A
309 WAVERLEY OAKS ROAD, SUITE 105
WALTHAM
MA
02452
1
0
0
0
Common Stock
2018-04-06
4
A
0
4687
1.36
A
66955
D
Common Stock
7557436
I
See Footnote
The Common Stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. Director Compensation Policy in lieu of the reporting person's quarterly retainer and any meeting fees of $6,375.
50,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
/s/ Louis A. Cannon
2018-04-10